Medication info

Olmatan 40mg (Olmesartan Medoxomil)

Prescription medicationTabletOralExpired
Ingredient · strength
Olmesartan Medoxomil›40mg / 1 tablet
Manufacturer / importer
Aprogen Pharmaceuticals, Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201906573 · Approved 2019.09.19

This product's status changed to Expired on 2024.09.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased up to a maximum of 40mg per day. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while carefully monitoring their condition. <Older adults> No dose adjustment is necessary when administering this medicine to older adults aged 65 years or older. No overall differences in efficacy or safety have been observed between older and younger patients; however, the possibility of a more sensitive response in some older adults cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose in patients with moderate hepatic impairment is 10mg once daily, which may be increased up to a maximum of 20mg per day. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.
Child dose
<Children> Safety and efficacy in children have not been established.

Ingredients

Manufacturer
Aprogen Pharmaceuticals, Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension refers to a condition where blood pressure remains chronically elevated, and this medication helps to control blood pressure and reduce the burden on the cardiovascular system. By managing hypertension, it contributes to the prevention of serious complications like stroke and myocardial infarction. Regular use can help maintain stable blood pressure. This medication dilates blood vessels, improves blood circulation, and reduces the burden on the heart. It can maximize effect when used in conjunction with other treatments. This medicine is used for the treatment of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased up to a maximum of 40mg per day. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while carefully monitoring their condition. <Older adults> No dose adjustment is necessary when administering this medicine to older adults aged 65 years or older. No overall differences in efficacy or safety have been observed between older and younger patients; however, the possibility of a more sensitive response in some older adults cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose in patients with moderate hepatic impairment is 10mg once daily, which may be increased up to a maximum of 20mg per day. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.

Child dose

<Children> Safety and efficacy in children have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this medication, pregnant or nursing women, patients on kidney dialysis, patients with severe liver impairment, patients with biliary obstruction, and those with lactose intolerance should not take this medication. Patients with low blood volume or sodium may experience symptoms of low blood pressure when first taking this medication, so careful monitoring is required, and appropriate actions should be taken if low blood pressure occurs. Patients with impaired kidney function, kidney transplant recipients, or patients with renovascular hypertension should periodically check kidney function and serum potassium levels while taking this medication. Due to the risk of hyperkalemia, individuals with heart failure or kidney disorders should have their serum potassium levels frequently assessed, and should take precautions when engaging in dangerous tasks or driving because dizziness may occur. Mild side effects like dizziness have been reported in clinical trials targeting hypertensive patients while rare cases of skin rash or angioedema may occur. If severe diarrhea or weight loss occurs while taking this medication, consult a doctor, and if symptoms similar to chronic malabsorption appear, discontinuation may be necessary. Taking concurrently with potassium-sparing diuretics, potassium supplements, lithium, non-steroidal anti-inflammatory drugs, etc., may elevate blood potassium levels or impact kidney function, hence informing the physician and exercising caution is advised. During pregnancy, this medication should be avoided for the health of the fetus, and during breastfeeding, consideration of discontinuation or stopping breastfeeding may be necessary to avoid effects on the baby. Safety in children has not been established, so it is advisable not to use in children. In case of overdose, symptoms of low blood pressure and palpitations may occur, and if symptoms are severe, immediate medical attention should be sought. This medication is known to have a low risk of carcinogenicity or genotoxicity even with prolonged use, but it should be taken with caution.

Side effects

  • Dizziness
  • back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 40 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • lightheadedness
  • abdominal pain
  • dyspepsia
  • gastritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • dyslipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • angioedema
  • anaphylaxis
  • vomiting
  • chronic malabsorption
  • rhabdomyolysis
  • hyperkalemia
  • acute kidney failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • hypertension
  • epistaxis
  • asthma
  • positional dizziness
  • palpitations
  • epistaxis
  • asthma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. The appropriate storage temperature is a cool place between 1°C and 25°C.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.